ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,138Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 890

$1.48M Total Retail Price of All Prescriptions

Rank: 13 out of 890

734 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
51% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 734 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

28% of this provider’s 734 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 19,454 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LEVOTHYROXINE SODIUM 1,233 1,022 1 2
HYDROCODONE-ACETAMINOPHEN 1,200 680 S3 2 3
SIMVASTATIN 753 568 3 5
METFORMIN HCL 673 511 4 6
GABAPENTIN 639 438 5 12
OMEPRAZOLE 612 432 6 8
AMLODIPINE BESYLATE 499 410 7 1
FUROSEMIDE 491 383 8 7
POTASSIUM CHLORIDE 467 355 9 11
BISOPROLOL FUMARATE 431 321 10 163
CITALOPRAM HBR 402 280 11 20
MELOXICAM 400 308 12 18
ZOLPIDEM TARTRATE 384 223 13 19
CARISOPRODOL 382 115 R 14 69
LISINOPRIL 348 288 15 4
LISINOPRIL-HYDROCHLOROTHIAZIDE 338 250 16 21
TRAZODONE HCL 332 232 17 40
ATORVASTATIN CALCIUM 326 270 18 13
TRAMADOL HCL 300 195 19 16
GLIMEPIRIDE 299 220 20 27
PRAVASTATIN SODIUM 250 205 21 10
CLOPIDOGREL 248 195 22 28
LOSARTAN POTASSIUM 247 228 23 29
NEXIUM 237 143 24 14
FENOFIBRATE 232 160 25 74
DONEPEZIL HCL 232 225 25 30
PANTOPRAZOLE SODIUM 231 171 27 34
CYMBALTA 231 104 27 45
FLUTICASONE PROPIONATE 226 172 29 39
AZITHROMYCIN 212 154 30 37
BISOPROLOL-HYDROCHLOROTHIAZIDE 205 150 31 122
ALLOPURINOL 203 162 32 31
SERTRALINE HCL 199 129 33 26
TAMSULOSIN HCL 184 162 34 32
HYDROCHLOROTHIAZIDE 182 144 35 9
PLAVIX 180 153 36 42
CRESTOR 177 140 37 25
SPIRONOLACTONE-HCTZ 177 140 37 273
WARFARIN SODIUM 165 137 39 24
ATENOLOL 149 100 40 23
CLONIDINE HCL 148 120 41 35
METOPROLOL SUCCINATE 144 90 42 17
DILTIAZEM 24HR ER 143 117 43 149
BYSTOLIC 143 112 43 86
LIPITOR 140 126 45 77
AMITRIPTYLINE HCL 139 93 R 46 43
OXYCODONE HCL-ACETAMINOPHEN 139 57 S2 46 127
KLOR-CON M20 135 121 48 72
CARVEDILOL 133 110 49 22
MORPHINE SULFATE ER 130 38 S2 50 207
PROAIR HFA 125 81 51 55
VERAPAMIL ER 121 120 52 87
ESTRADIOL 121 57 R 52 118
ADVAIR DISKUS 121 108 52 52
LANTUS 120 94 55 50
PREMARIN 120 84 R 55 105
SYNTHROID 119 103 57 53
NAMENDA 118 115 58 36
LEVOFLOXACIN 118 81 58 107
POLYETHYLENE GLYCOL 3350 116 100 60 67
LOSARTAN-HYDROCHLOROTHIAZIDE 116 105 60 57
LOVASTATIN 116 80 60 46
FINASTERIDE 114 114 63 108
KLOR-CON 10 113 87 64 189
METHYLPREDNISOLONE 112 72 65 109
GLYBURIDE-METFORMIN HCL 110 104 R 66 115
VENLAFAXINE HCL ER 103 36 67 114
MECLIZINE HCL 101 83 68 97
ESCITALOPRAM OXALATE 101 73 68 51
MUPIROCIN 99 58 70 121
ZETIA 98 70 71 81
METOPROLOL TARTRATE 98 70 71 15
PROMETHAZINE HCL 97 42 R 73 104
RISPERIDONE 92 77 74 78
SULFAMETHOXAZOLE-TRIMETHOPRIM 91 56 75 76
ENDOCET 91 47 S2 75 218
PROPRANOLOL HCL 90 74 77 141
DILTIAZEM ER 90 61 77 129
ALPRAZOLAM 90 76 77 95
FAMOTIDINE 90 80 77 90
CELEBREX 89 54 81 91
OXYBUTYNIN CHLORIDE 88 78 82 139
AMLODIPINE BESYLATE-BENAZEPRIL 88 87 82 41
DIOVAN 87 76 84 33
FENTANYL 85 38 S2 85 151
PREDNISONE 84 54 86 47
LYRICA 84 38 86 71
SPIRIVA 84 56 86 66
PAROXETINE HCL 83 60 89 68
OXYCODONE HCL 82 0 S2 90 123
DEXILANT 81 50 91 138
SINGULAIR 80 54 92 79
TORSEMIDE 80 62 92 159
AMOX TR-POTASSIUM CLAVULANATE 79 53 94 132
FLUOXETINE HCL 79 51 94 63
THEOPHYLLINE ANHYDROUS 77 53 96 243
RANITIDINE HCL 77 71 96 49
FOSINOPRIL SODIUM 73 30 98 184
TRIAMTERENE-HCTZ 72 72 99 61
JANUVIA 71 60 100 59
CYCLOBENZAPRINE HCL 71 21 R 100 64
TRICOR 71 53 100 98
ALENDRONATE SODIUM 69 69 103 38
HYDROMORPHONE HCL 68 52 S2 104 316
CEPHALEXIN 67 39 105 119
NABUMETONE 66 38 106 143
BUPROPION XL 65 41 107 190
CLOTRIMAZOLE-BETAMETHASONE 65 43 107 152
LACTULOSE 63 59 109 112
EVISTA 63 49 109 182
INSULIN SYRINGE 62 42 111 99
LEVOCETIRIZINE DIHYDROCHLORIDE 61 47 112 131
FLUCONAZOLE 61 32 112 155
DIPHENOXYLATE-ATROPINE 60 32 114 358
ISOSORBIDE MONONITRATE ER 60 38 114 60
DILTIAZEM 24HR CD 59 45 116 156
NYSTATIN 58 43 117 173
CIPROFLOXACIN HCL 58 56 117 58
LEVEMIR 57 36 119 322
DOXYCYCLINE HYCLATE 55 40 120 89
DIOVAN HCT 53 26 121 48
SOTALOL 50 50 122 269
VESICARE 50 40 122 188
DIGOXIN 50 50 122 65
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 24, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.